Epigenetic Editing Could Wipe Out Chronic Hepatitis B Infections
AI-rewritten: This is a summary of an article from Singularity Hub, rewritten by AI (Qwen, running locally) to make it easier to read. The facts come from the original article – read it for the full story.
Scientists have developed an experimental therapy that keeps the hepatitis B virus inactive for at least six months in mice. This approach, called epigenetic silencing, adds chemical tags to viral DNA to switch genes off without cutting the genetic material. Unlike gene editing tools that can damage host DNA, this method aims to be safer while remaining long-lasting. After three monthly doses, roughly 90 percent of treated mice showed no signs of the virus for six months following their final injection. Safety tests in monkeys found no notable side effects or runaway immune responses.